SLC7A11 is highly expressed in many types of tumors such as acute myeloid leukemia, breast cancer, colorectal cancer, hepatocellular carcinoma, glioma, etc., and its high expression is associated with poor prognosis of patients with cancers [13,14]. Here, SLC7A11 is linked to colorectal cancer.